RESEARCH & THOUGHTS
Perspectives Shaping Clinical Development
Discover engaging resources driving the conversation forward and on-demand demo videos showcasing the very solutions forming the future of our field.
Multicenter studies are widely used to meet accrual targets in clinical trials. Clinical data monitoring...
Download
Multicenter studies are widely used to meet accrual targets in clinical trials. Clinical data monitoring...
Download
Highly publicized cases of fabrication or falsification of data in clinical trials have occurred in recent...
Download
Errors in the design, the conduct, the data collection process, and the analysis of a randomized trial...
Download
The study was terminated after two years, while the main randomized trial continued. Of the 135 centers...
Download
Highly publicized cases of fabrication or falsification of data in clinical trials have occurred in recent...
Download
- Blog
Harnessing Risk-Based Quality Management And Deep Learning To Improve Trial Knowledge And Drive Better Outcomes – Your Questions Answered
- Blog
The Importance Of Risk Assessment As A Foundation Of RBQM
- Blog
10 Reasons People Like Working At CluePoints
- Blog
RBQM And ML: Perfect Partners For More Efficient Clinical Trials
- Research Paper
Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator Outcomes
- Blog
Twin Peaks: 10 Years Of CluePoints And Risk-Based Monitoring
- Blog
The Inaugural ACDM AI & ML Conference Promises To Move The Dial
- Blog
Natural Language Processing Improves Risk Signal Documentation In Clinical Trials
- Blog
The Best Of Both: The Key Reasons To Outsource RBQM Tech But Keep Data Control
- Blog
10 Reasons Why CROs Leverage CluePoints For RBQM
- Blog
CluePoints To Share Case Study On Technology ROI At The SCDM 2022 EMEA Leadership Forum & Conference
- Blog
Join Us At DIA 2022 As We Demystify The De-Risking Of DCTs
- Blog
Webinar: Risk-Based Monitoring Implementation – What Does ICH E6 Rev2 Mean For My Company?
- Blog
CluePoints Answers Your Risk-Based Monitoring Implementation Questions
- Blog
Risk-Based Monitoring Insights From The Industry: Angie Maurer
- Blog
Risk-Based Monitoring Insights From The Industry: Jamie O’Keefe
- Blog
Risk-Based Monitoring Insights From The Industry: Steve Young
- Blog
Defining Clinical Trial Thresholds: Objective Vs Subjective?
- Blog
Central Statistical Monitoring Should Support Key Risk Indicators
- Blog
Are The Regulatory Authorities Ready For The Adoption Of Risk-Based Monitoring?
- Blog
Risk-Based Monitoring Insights From The Industry: Dr. Peter Schiemann
- Blog
How Will Risk-Based Monitoring Coexist With Other Clinical Trial Technology?
- Blog
Risk-Based Monitoring Insights From The Industry: Karen Fanouillere
- Blog
Risk-Based Monitoring Insights And Strategies From The Industry: Adam Butler
